Similar articles for PMID: 3680527

Year	Number of Results
1926	1
1948	1
1953	1
1961	1
1969	1
1971	1
1975	1
1976	2
1978	5
1979	2
1980	2
1981	3
1982	4
1983	3
1984	13
1985	16
1986	29
1987	29
1988	36
1989	22
1990	25
1991	24
1992	32
1993	26
1994	21
1995	16
1996	19
1997	15
1998	14
1999	19
2000	7
2001	9
2002	5
2003	7
2004	4
2005	4
2006	1
2007	1
2008	4
2009	2
2010	3
2011	6
2012	5
2013	6
2014	5
2015	4
2016	7
2017	8
2018	7
2019	5
2020	5
2021	4
2022	9
2023	7
2024	2

1

Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.

Wanders RJ, van Roermund CW, van Wijland MJ, Schutgens RB, Heikoop J, van den Bosch H, Schram AW, Tager JM. Wanders RJ, et al. J Clin Invest. 1987 Dec;80(6):1778-83. doi: 10.1172/JCI113271. J Clin Invest. 1987. PMID: 3680527 Free PMC article.

2

New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.

Van Veldhoven PP. Van Veldhoven PP. Verh K Acad Geneeskd Belg. 1998;60(3):195-214. Verh K Acad Geneeskd Belg. 1998. PMID: 9803880 Review.

3

Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.

Aubourg P, Kremser K, Roland MO, Rocchiccioli F, Singh I. Aubourg P, et al. Pediatr Res. 1993 Sep;34(3):270-6. doi: 10.1203/00006450-199309000-00006. Pediatr Res. 1993. PMID: 7510868

4

Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.

Wanders RJ, van Roermund CW, van Wijland MJ, Heikoop J, Schutgens RB, Schram AW, Tager JM, van den Bosch H, Poll-Thé BT, Saudubray JM, et al. Wanders RJ, et al. Clin Chim Acta. 1987 Jul 15;166(2-3):255-63. doi: 10.1016/0009-8981(87)90428-1. Clin Chim Acta. 1987. PMID: 2441904

5

Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases.

Suzuki Y, Shimozawa N, Yajima S, Yamaguchi S, Orii T, Hashimoto T. Suzuki Y, et al. Biochem Pharmacol. 1991 Feb 1;41(3):453-6. doi: 10.1016/0006-2952(91)90544-f. Biochem Pharmacol. 1991. PMID: 1994902

6

Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.

Molzer B, Kainz-Korschinsky M, Sundt-Heller R, Bernheimer H. Molzer B, et al. J Clin Chem Clin Biochem. 1989 May;27(5):309-14. J Clin Chem Clin Biochem. 1989. PMID: 2474624

7

[Peroxisomal beta-oxidation].

Mannaerts GP, Van Veldhoven PP. Mannaerts GP, et al. Verh K Acad Geneeskd Belg. 1993;55(1):45-78. Verh K Acad Geneeskd Belg. 1993. PMID: 8480447 Review. Dutch.

8

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.

Lazo O, Contreras M, Hashmi M, Stanley W, Irazu C, Singh I. Lazo O, et al. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7647-51. doi: 10.1073/pnas.85.20.7647. Proc Natl Acad Sci U S A. 1988. PMID: 3174658 Free PMC article.

9

Straight-chain acyl-CoA oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases.

Infante JP, Tschanz CL, Shaw N, Michaud AL, Lawrence P, Brenna JT. Infante JP, et al. Mol Genet Metab. 2002 Feb;75(2):108-19. doi: 10.1006/mgme.2001.3279. Mol Genet Metab. 2002. PMID: 11855929

10

[The contribution of peroxisomes to lipid metabolism].

Kramar R. Kramar R. J Clin Chem Clin Biochem. 1986 Feb;24(2):109-18. J Clin Chem Clin Biochem. 1986. PMID: 3711795 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

493 results

Results by year